Oncogene Proteins, Fusion | Profiles RNS
Fusion" by people in UAMS Profiles by year, and whether "Oncogene Proteins, Fusion" was a major or minor topic of these ... "Oncogene Proteins, Fusion" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular ... Below are the most recent publications written about "Oncogene Proteins, Fusion" by people in Profiles over the past ten years. ...
ETV6-NTRK3 gene fusion - Wikipedia
Stenman G (July 2013). "Fusion oncogenes in salivary gland tumors: molecular and clinical consequences". Head and Neck ... ETV6-NTRK3 gene fusion is the translocation of genetic material between the ETV6 gene located on the short arm (designated p) ... Indeed, the ETV6-NTRK3 fusion gene appears to be a critical driver of several types of cancers. It was originally identified in ... Wai DH, Knezevich SR, Lucas T, Jansen B, Kay RJ, Sorensen PH (February 2000). "The ETV6-NTRK3 gene fusion encodes a chimeric ...
RAB8A RAB8A, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI
involved_in Golgi vesicle fusion to target membrane IBA Inferred from Biological aspect of Ancestor. more info ... mel transforming oncogene (RAB8 homolog). mel transforming oncogene (derived from cell line NK14). mel transforming oncogene ( ... RAB8A RAB8A, member RAS oncogene family [Homo sapiens] RAB8A RAB8A, member RAS oncogene family [Homo sapiens]. Gene ID:4218 ... RAB8A, member RAS oncogene familyprovided by HGNC. Primary source. HGNC:HGNC:7007 See related. Ensembl:ENSG00000167461 MIM: ...
EHE - Epithelial Hemangio-Endothelioma, cancer driven by fusions of YAP or TAZ oncogenes with genes that encode transcription...
Rare-sarcomas; Cancers driven by a single oncogene; Fusion-genes and the mechanism of their activation as fusion proteins, ... Because cancer-driven by a single oncogene, such as leukemia driven by the BCR-ABL fusion gene, is amenable to treatment with ... EHE - Epithelial Hemangio-Endothelioma, cancer driven by fusions of YAP or TAZ oncogenes with genes that encode transcription ... Although two newly described oncogenes known as YAP and TAZ are not generally mutated in human cancers, there is one exception ...
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity | Nature Communications
While studies of selected MLL-fusions have revealed critical molecular pathways, unifying mechanisms across all MLL-fusions ... In leukemia, diverse fusion proteins involving the MLL gene can drive oncogenic activity. Here, the authors describe a ... We present the first comprehensive survey of protein-protein interactions of seven distantly related MLL-fusion proteins. ... Functional investigation of 128 conserved MLL-fusion-interactors identifies a specific role for the lysine methyltransferase ...
Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic...
... as well as the mechanisms by which oncogenes disrupt this process, remain poorly understood. A major limitation in approaching ... Oncogene Proteins * Oncogene Proteins, Fusion / analysis * Oncogene Proteins, Fusion / metabolism* * Phagocytosis * Point ... The molecular pathways of normal myeloid differentiation, as well as the mechanisms by which oncogenes disrupt this process, ... conditional immortalization of primary murine marrow progenitors with an estrogen-regulated E2a/Pbx1-estrogen receptor fusion ...
EGR1 reactivation by histone deacetylase inhibitors promotes synovial sarcoma cell death through the PTEN tumor suppressor |...
Structural, biochemical, and functional analyses of CED-9 recognition by the proapoptotic proteins EGL-1 and CED-4
YES1 (YES proto-oncogene 1, Src family tyrosine kinase)
A/Prof Kate Sutherland, Lab Head | WEHI Researcher Profile
New developments in the molecular pathogenesis of head and neck tumors: A review of tumor-specific fusion oncogenes in...
... chimeric oncogene. Tumor-specific recurrent chromosomal translocations and novel fusion oncogenes in aggressive head and neck ... chimeric oncogene. Tumor-specific recurrent chromosomal translocations and novel fusion oncogenes in aggressive head and neck ... chimeric oncogene. Tumor-specific recurrent chromosomal translocations and novel fusion oncogenes in aggressive head and neck ... chimeric oncogene. Tumor-specific recurrent chromosomal translocations and novel fusion oncogenes in aggressive head and neck ...
S100A10 | Cancer Genetics Web
In this fusion gene, the part of CSF1 coding for the CSF1 protein (exons 1-8 in sequences with accession nos. NM_000757 and NM_ ... AnxA2 and SOX2 bind to proto-oncogenes, c-Myc and c-Src, and AnxA2 forms a functional heterotetramer with S100A10 to promote ... Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors.. Int J Oncol ... A novel CSF1-S100A10 fusion gene was found in a TSGCT that carried the translocation t(1;1)(q21;p11) as the sole karyotypic ...
Current Oncology | Free Full-Text | Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults
... gene fusions. These NTRK gene fusions are oncogenic drivers found in most tumour types at a low frequency (,5%), and at a ... We provide a Canadian consensus on when and how to test for NTRK gene fusions and when to consider treatment with a TRK ... Based on the probability of the tumour harbouring an NTRK gene fusion, we also suggest a tumour-agnostic consensus for NTRK ... We recommend considering a TRK inhibitor in all patients with TRK fusion cancer with no other effective treatment options. ...
Childhood cancer risk in those with chromosomal and non-chromosomal congenital anomalies in Washington State: 1984-2013 | PLOS...
The Journal of Contemporary Dental Practice
Chromosome 21: MedlinePlus Genetics
AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. Oncogene. 2001 Sep 10;20(40):5660-79. doi: 10.1038/sj. ... The RUNX1-ETO fusion protein forms CBF and attaches to DNA, but instead of turning on genes that stimulate the development of ... The fusion protein produced from the t(8;21) translocation, called RUNX1-ETO, retains some functions of the two individual ...
Publications from CCI Users and Staff | University of Gothenburg
"Regulatory Mechanisms, Expression Levels and Proliferation Effects of the Fus-Ddit3 Fusion Oncogene in Liposarcoma." J Pathol ... Functional characterization of the liposarcoma-associated fusion oncogene FUS-DDIT3. 2005. Surpervisor: Pierre Åman. Lachmi ... SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity.. Boström P, Andersson ... A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins.. ...
Ewing Sarcoma: Diagnosis, Treatment, Research and Support
Loss of tumorigenicity of Ewings sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene. 1995 Sep 21;11(6 ... Oncogene. 2010 Jun 14. [Epub ahead of print] Toretsky JA, Erkizan V, Levenson A, Abaan OD, Parvin JD, Cripe TP, Rice AM, Lee SB ... The EWS/FLI Fusion Protein. The Ewing sarcoma gene encodes protein of uncertain function, while the FLI product is a ... Joint fusions often result in dissatisfied patients because of the lack of joint motion. They are better tolerated for the ...
New England Journal of Medicine Publishes Phase 1/2 Data for Retevmo™ (selpercatinib) in Advanced RET-Driven Lung and Thyroid...
RET Fusion-Positive NSCLC. The publication highlights the first 105 consecutively enrolled RET fusion-positive metastatic NSCLC ... This dependency, often referred to as "oncogene addiction," renders such tumors highly susceptible to small molecule inhibitors ... RET fusion-positive cancers and RET-mutant MTC are primarily dependent on this single activated kinase for their proliferation ... NEJM published separate articles focusing on efficacy and safety data in the RET fusion-positive NSCLC and RET-altered thyroid ...
Medscape | J Clin Endocrinol Metab - Content Listing
Propofol suppresses gastric cancer tumorigenesis by modulating the circular RNA‑PVT1/miR‑195‑5p/E26 oncogene homolog 1 axis
... to generate fusion plasmids, and a pcDNA empty vector was used as the control. For miR-195-5p enrichment or inhibition, miR-195 ... EST1 is considered to be a pro-oncogene that regulates the pathophysiological progress of GC (45). It has been reported that ... Propofol suppresses gastric cancer tumorigenesis by modulating the circular RNA‑PVT1/miR‑195‑5p/E26 oncogene homolog 1 axis. * ... Circ-PVT1, circular RNA-PVT1; ETS1, E26 oncogene homolog; miR-195-5p, microRNA-195-5p; NC, negative control; anti-miR-195-5p, ...
ROS1 mutation | Radiology Reference Article | Radiopaedia.org
Ghent University Academic Bibliography
CD44 Antibodies
Clinical Chemistry and Laboratory Medicine (CCLM) Volume 51 Issue 9
Background: EML4-ALK fusion oncogene has emerged as a novel molecular target in non-small cell lung cancer (NSCLC). Although ... Conclusions: Highly specific and sensitive detection of EML4-ALK fusion oncoprotein is possible by in situ PLA method ... Sensitive detection of EML4-ALK fusion oncoprotein of lung cancer by in situ proximity ligation assay. ... EML4-ALK oncogene and protein in lung cancer cells were confirmed by multiplex RT-PCR and Western blots. Results: We detected ...
Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial | Citedby...
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow- ... Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial. Clin ... RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report ... The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A ...
Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer |...
... we annotated the gene fusions using published databases for gene fusions in cancer. To relate the occurrence of gene fusions to ... These fusions were detected in all four studied cohorts, providing compelling evidence for the validity of these fusions and ... With the fusion calling software Arriba, we computationally predicted gene fusions. Following detection, ... Our gene fusion characterization workflow revealed two potential novel fusions specific for PCa. We found evidence that the ...
FYN | Cancer Genetics Web
... usually involving former proto-oncogenes) and may therefore be successfully inhibited by substances directed against the fusion ... Synstable Fusion: A Network-Based Algorithm for Estimating Driver Genes in Fusion Structures.. Molecules. 2018; 23(8) [PubMed] ... In this paper, Synstable Fusion (SYN), an algorithm for computationally evaluating the fusion genes, is proposed. This ... different methods sometimes suffer different weaknesses when handling gene fusion data due to multiple issues such as fusion ...